Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magellan Bioanalytics provides AI-driven, machine learning-based analytical solutions to extract clinically relevant insights from large-scale mass spectrometry and omics datasets. Their proprietary platforms enable healthcare companies to identify patient subgroups most likely to benefit from specific oncology drugs, supporting precision medicine initiatives. The company claims industry-leading scale in feature extraction per sample and is developing next-generation tools for integrating multiomics datasets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magellan Bioanalytics.